Jupiter Neurosciences Stock Plummets After Violent Session
Jupiter Neurosciences, Inc.'s stock had one of its most volatile sessions on record. On August 21, 2026, shares opened at $8.20 and spiked to a high of $11.14 before collapsing to close at $6.20.
The daily EMA structure remains bullish, with price above the EMA20 (3.56), EMA50 (1.99), and EMA200 (1.08). However, the RSI14 at 78.21 signals overbought conditions.
The company's clinical-stage profile and thin market cap leave it highly exposed to headline-driven swings. A recent article highlighted Jupiter Neurosciences' approach to Parkinson's Disease, noting its potential but also its small market cap of $5.0 million.